Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
Hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, 110th Congress, 1st Session, May 2, 2007, Serial No. 110-40
Other books by this author
Do you want to exchange books? It’s EASY!
Get registered and find other users who want to give their favourite books to good hands!
